Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
ANAB · NASDAQ · Pharmaceutical Preparations
$46.63−0.77 (−1.62%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Anaptysbio (ANAB) · oqro.io/stocks/ANAB · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
5%+ stake, activist · Stake as of Nov 16, 2026 · Filed Nov 18, 2026
EcoR1 Capital, LLC disclosed a 27.8% stake in ANAB and may seek to influence the companySourceInsider trade · Traded Nov 16, 2026 · Filed Nov 18, 2026
Director purchased ~$3.84M of ANAB shares in the open marketSourceInsider trade · Traded Nov 17, 2026 · Filed Nov 18, 2026
Director purchased ~$6.96M of ANAB shares in the open marketSourceInsider trade · Traded Nov 18, 2026 · Filed Nov 18, 2026
Director purchased ~$6.43M of ANAB shares in the open marketSource5%+ stake · Stake as of Sep 30, 2026 · Filed Nov 16, 2026
Sirenia Capital Management LP cut its ANAB stake below 5% (3.1%)SourceInsider trade · Traded Oct 1, 2026 · Filed Oct 2, 2026
Director sold ~$249K of ANAB shares in the open marketSourceInsider trade · Traded Aug 8, 2025 · Filed Aug 12, 2025
Director sold ~$140K of ANAB shares in the open marketSourceInsider trade · Traded Aug 8, 2025 · Filed Aug 12, 2025
Director sold ~$60K of ANAB shares in the open marketSourceInsider trade · Traded Jul 2, 2025 · Filed Jul 3, 2025
Director sold ~$326K of ANAB shares in the open marketSourceInsider trade · Traded Jul 2, 2025 · Filed Jul 3, 2025
Director sold ~$167K of ANAB shares in the open marketSourceInsider trade · Traded Jun 18, 2025 · Filed Jun 20, 2025
Director sold ~$72K of ANAB shares in the open marketSourceInsider trade · Traded Jun 18, 2025 · Filed Jun 20, 2025
Director sold ~$72K of ANAB shares in the open marketSourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Frazier Life Sciences Management, L.P. no longer reported ANAB for Q1 2025SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 18, 2025
Frazier Life Sciences Management, L.P. disclosed a reduced position in ANAB for Q4 2024SourceInsider trade · Traded Dec 30, 2024 · Filed Jan 2, 2025
Director purchased ~$842K of ANAB shares in the open marketSourceInsider trade · Traded Dec 31, 2024 · Filed Jan 2, 2025
Director purchased ~$172K of ANAB shares in the open marketSourceInsider trade · Traded Jan 2, 2025 · Filed Jan 2, 2025
Director purchased ~$86K of ANAB shares in the open marketSourceInsider trade · Traded Nov 29, 2024 · Filed Dec 3, 2024
Director sold ~$250K of ANAB shares in the open marketSourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 15, 2024
Frazier Life Sciences Management, L.P. disclosed an increased position in ANAB for Q3 2024Source